Clinical trial
A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
NCT01787227 is registered in ClinicalTrials.gov with Luminex Molecular Diagnostics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel (NxTAG RPP) in Patients With Clinical Signs and Symptoms of Respiratory Tract Infection
- Lead sponsor
- Luminex Molecular Diagnostics
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- Not reported
- Enrollment
- 1,500 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
bronchiolitis, bronchitis, pneumonia, respiratory tract infection